Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network

N Engl J Med. 1994 Feb 10;330(6):438-9. doi: 10.1056/NEJM199402103300616.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • Bacteremia / drug therapy*
  • Clarithromycin / administration & dosage
  • Clarithromycin / therapeutic use
  • Drug Therapy, Combination
  • Ethambutol / administration & dosage
  • Ethambutol / therapeutic use
  • Humans
  • Jaundice / chemically induced*
  • Mycobacterium avium-intracellulare Infection / drug therapy*
  • Prospective Studies
  • Rifabutin / administration & dosage
  • Rifabutin / adverse effects*
  • Uveitis / chemically induced*

Substances

  • Rifabutin
  • Ethambutol
  • Clarithromycin